VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Thursday, January 1, 2026
Stock Comparison
Parker-Hannifin Corporation vs Roche Holding AG
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Parker-Hannifin Corporation
PH · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Parker-Hannifin Corporation's moat claims, evidence, and risks.
View PH analysisRoche Holding AG
ROG · SIX Swiss Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Roche Holding AG's moat claims, evidence, and risks.
View ROG analysisComparison highlights
- Moat score gap: Parker-Hannifin Corporation leads (71 / 100 vs 68 / 100 for Roche Holding AG).
- Segment focus: Parker-Hannifin Corporation has 2 segments (68.8% in Diversified Industrial); Roche Holding AG has 2 segments (76.3% in Pharmaceuticals).
- Moat breadth: Parker-Hannifin Corporation has 5 moat types across 2 domains; Roche Holding AG has 5 across 3.
Primary market context
Parker-Hannifin Corporation
Diversified Industrial
Motion and control components & systems (industrial and mobile applications)
Global
OEMs and industrial distributors/aftermarket channels
Component and system designer/manufacturer with aftermarket support
68.8%
Roche Holding AG
Pharmaceuticals
Innovative (branded) prescription pharmaceuticals
Global
Healthcare providers and systems (hospitals/clinics), payers/governments, and patients
Innovator pharmaceutical developer, manufacturer and marketer
76.3%
Side-by-side metrics
Moat coverage
Shared moat types
Parker-Hannifin Corporation strengths
Roche Holding AG strengths
Segment mix
Parker-Hannifin Corporation segments
Full profile >Diversified Industrial
Competitive
Aerospace Systems
Oligopoly
Roche Holding AG segments
Full profile >Pharmaceuticals
Competitive
Diagnostics
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.